Renewal of Milner Therapeutics Consortium
We are delighted to announce that the Milner Therapeutics Consortium has been renewed until 2024. The Consortium includes 7 pharma companies (Astex, AstraZeneca, Ferring, GlaxoSmithKline, J & J Innovation, Pfizer, Shionogi) who are committed to collaboration and...
New Opportunity for an Administrator and Finance Coordinator
Administrator and Finance Coordinator We are looking to appoint a new and key role in our brand new purpose built facilities in the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus. This is an exciting and challenging opportunity for a motivated...
Cambridge Biotech Week
The Milner Therapeutics Symposium 2019 is part of Cambridge Biotech Week (25-28th June), a festival of events focused on accelerating scientific ideas and facilitating investment and growth for both early and mature companies on the cutting-edge of healthcare and life...
Start Codon announced as new world-class life science accelerator
This innovative new accelerator programme will provide significant funding and support for selected start-ups, with office and lab space in the Milner Research Labs.
